5090 Federal Register / Vol. 75, No. 20 / Monday, February 1, 2010 / Notices 

Contact Person for More Information: J 

Felix Rogers, PhD, M.P.H., Telephone 

(770) 488–4334, NCIPC/ERPO, CDC, 4770 

Buford Highway, NE., M/S F63, Atlanta, 

Georgia 30341–3724. 

The Director, Management Analysis and 

Services Office has been delegated the 

authority to sign Federal Register notices 

pertaining to announcements of meetings and 

other committee management activities for 

both CDC and the Agency for Toxic 

Substances and Disease Registry. 

Dated: January 22, 2010. 

Elaine L. Baker, 

Director, Management Analysis and Services 

Office, Centers for Disease Control and 

Prevention. 

[FR Doc. 2010–2002 Filed 1–29–10; 8:45 am] 

BILLING CODE 4163–18–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Heart, Lung, and Blood 

Institute; Notice of Closed Meetings 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended (5 U.S.C. App.), notice is 

hereby given of the following meetings. 

The meetings will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Heart, Lung, 

and Blood Institute Special Emphasis Panel, 

Science Moving Towards Research 

Translation and Therapy (SMARTT)—NonBiologics and Small Molecules Production 

Facility. 

Date: February 23, 2010. 

Time: 8:30 a.m. to 11 a.m. 

Agenda: To review and evaluate contract 

proposals. 

Place: Hyatt Regency Bethesda, One 

Bethesda Metro Center, 7400 Wisconsin 

Avenue, Bethesda, MD 20814. 

Contact Person: William J Johnson, PhD, 

Scientific Review Officer, Review Branch/ 

DERA, National Heart, Lung, and Blood 

Institute, 6701 Rockledge Drive, Room 7178, 

Bethesda, MD 20892–7924. 301–435–0725. 

johnsonwj@nhlbi.nih.gov. 

Name of Committee: National Heart, Lung, 

and Blood Institute Special Emphasis Panel, 

Science Moving Towards Research 

Translation and Therapy (SMARTT)— 

Biologics Production Facility. 

Date: February 23, 2010. 

Time: 11:30 a.m. to 1 p.m. 

Agenda: To review and evaluate contract 

proposals. 

Place: Hyatt Regency Bethesda, One 

Bethesda Metro Center, 7400 Wisconsin 

Avenue, Bethesda, MD 20814. 

Contact Person: William J Johnson, PhD, 

Scientific Review Officer, Review Branch/ 

DERA, National Heart, Lung, and Blood 

Institute, 6701 Rockledge Drive, Room 7178, 

Bethesda, MD 20892–7924. 301–435–0725. 

johnsonwj@nhlbi.nih.gov. 

Name of Committee: National Heart, Lung, 

and Blood Institute Special Emphasis Panel, 

Science Moving Towards Research 

Translation and Therapy (SMARTT)— 

Pharmacology/Toxicology Center. 

Date: February 23, 2010. 

Time: 1:30 p.m. to 4 p.m. 

Agenda: To review and evaluate contract 

proposals. 

Place: Hyatt Regency Bethesda, One 

Bethesda Metro Center, 7400 Wisconsin 

Avenue, Bethesda, MD 20814. 

Contact Person: William J Johnson, PhD, 

Scientific Review Officer, Review Branch/ 

DERA, National Heart, Lung, and Blood 

Institute, 6701 Rockledge Drive, Room 7178, 

Bethesda, MD 20892–7924. 301–435–0725. 

johnsonwj@nhlbi.nih.gov. 

Name of Committee: National Heart, Lung, 

and Blood Institute Special Emphasis Panel, 

Science Moving Towards Research 

Translation and Therapy (SMARTT) 

Coordinating Center. 

Date: February 24, 2010. 

Time: 8:30 a.m. to 11:30 a.m. 

Agenda: To review and evaluate contract 

proposals. 

Place: Hyatt Regency Bethesda, One 

Bethesda Metro Center, 7400 Wisconsin 

Avenue, Bethesda, MD 20814. 

Contact Person: William J Johnson, PhD, 

Scientific Review Officer, Review Branch/ 

DERA, National Heart, Lung, and Blood 

Institute, 6701 Rockledge Drive, Room 7178, 

Bethesda, MD 20892–7924. 301–435–0725. 

johnsonwj@nhlbi.nih.gov. 

Name of Committee: National Heart, Lung, 

and Blood Institute Special Emphasis Panel, 

Pathway to Independence Award (K99’s). 

Date: February 25–26, 2010. 

Time: 8 a.m. to 5 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: The Mandarin Oriental, 1330 

Maryland Avenue, SW., Washington, DC 

20024. 

Contact Person: Holly K Krull, PhD, 

Scientific Review Officer, Review Branch/ 

DERA, National Heart, Lung, and Blood 

Institute, 6701 Rockledge Drive, Room 7188, 

Bethesda, MD 20892–7924. 301–435–0280. 

krullh@nhlbi.nih.gov. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.233, National Center for 

Sleep Disorders Research; 93.837, Heart and 

Vascular Diseases Research; 93.838, Lung 

Diseases Research; 93.839, Blood Diseases 

and Resources Research, National Institutes 

of Health, HHS) 

Dated: January 26, 2010. 

Jennifer Spaeth, 

Director, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2010–2035 Filed 1–29–10; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Agency for Healthcare Research and 

Quality 

Notice of Meeting 

In accordance with section 10(d) of 

the Federal Advisory Committee Act (5 

U.S.C., Appendix 2), announcement is 

made of a Health Care Policy and 

Research Special Emphasis Panel (SEP) 

meeting. 

A Special Emphasis Panel is a group 

of experts in fields related to health care 

research who are invited by the Agency 

for Healthcare Research and Quality 

(AHRQ), and agree to be available, to 

conduct on an as-needed basis, 

scientific reviews of applications for 

AHRQ support. Individual members of 

the Panel do not attend regularly 

scheduled meetings and do not serve for 

fixed terms or a long period of time. 

Rather, they are asked to participate in 

particular review meetings which 

require their type of expertise. 

Substantial segments of the upcoming 

SEP meeting listed below will be closed 

to the public in accordance with the 

Federal Advisory Committee Act, 

section 10 (d) of 5 U.S.C., Appendix 2 

and 5 U.S.C. 552b(c)(6). Grant 

applications for the ARRA: Limited 

Competition ‘‘AHRQ Institutional 

Training Grants for CE’’ (K12) 

applications are to be reviewed and 

discussed at this meeting. These 

discussions are likely to reveal personal 

information concerning individuals 

associated with the applications. This 

information is exempt from mandatory 

disclosure under the above-cited 

statutes. 

SEP Meeting on: ARRA: Limited 

Competition ‘‘AHRQ Institutional Training 

Grants for CE’’ (K12). 

Date: March 3, 2010 (Open on March 3 

from 8:00 a.m. to 8:15 a.m. and closed for the 

remainder of the meeting). 

Place: Hilton Rockville Executive Meeting 

Center, 1750 Rockville Pike, Madison 

Conference Room, Rockville, Maryland 

20850. 

Contact Person: Anyone wishing to obtain 

a roster of members, agenda or minutes of the 

nonconfidential portions of this meeting 

should contact Mrs. Bonnie Campbell, 

Committee Management Officer, Office of 

Extramural Research, Education and Priority 

Populations, AHRQ, 540 Gaither Road, Room 


jlentini on DSKJ8SOYB1PROD with NOTICES
Federal Register / Vol. 75, No. 20 / Monday, February 1, 2010 / Notices 5091 

2038, Rockville, Maryland 20850, Telephone 

(301) 427–1554. 

Agenda items for this meeting are subject 

to change as priorities dictate. 

Dated: January 25, 2010. 

Carolyn M. Clancy, 

Director. 

[FR Doc. 2010–1901 Filed 1–29–10; 8:45 am] 

BILLING CODE 4160–90–M 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

Office of the Director, National 

Institutes of Health; Notice of Meeting 

Pursuant to section 10(a) of the 

Federal Advisory Committee Act, as 

amended (5 U.S.C. App.), notice is 

hereby given of a meeting of the Office 

of AIDS Research Advisory Council. 

The meeting will be open to the 

public, with attendance limited to space 

available. Individuals who plan to 

attend and need special assistance, such 

as sign language interpretation or other 

reasonable accommodations, should 

notify the Contact Person listed below 

in advance of the meeting. 

Name of Committee: Office of AIDS 

Research Advisory Council. 

Date: March 18, 2010. 

Time: 8:30 a.m. to 5 p.m. 

Agenda: The theme of the meeting will be 

‘‘HIV/AIDS and Aging.’’ The meeting will 

address issues related to: increased rates of 

new infections among older adults; impact of 

long-term use of antiretroviral therapies in 

HIV-infected individuals; and premature 

aging in HIV-infected individuals. An update 

also will be provided on the OARAC 

Working Groups for HIV Treatment and 

Prevention Guidelines. 

Place: National Institutes of Health, 5635 

Fishers Lane, Rockville, MD 20852. 

Contact Person: Christina Brackna, 

Coordinator, Program Planning and Analysis, 

Office of Aids Research, Office of the 

Director, NIH, 5635 Fishers Lane MSC 9310, 

Suite 4000, Rockville, MD 20852, (301) 402– 

8655, cm53v@nih.gov. 

Any interested person may file written 

comments with the committee by forwarding 

the statement to the Contact Person listed on 

this notice. The statement should include the 

name, address, telephone number and when 

applicable, the business or professional 

affiliation of the interested person. 

Information is also available on the 

Institute’s/Centers home page: http:// 

www.oar.nih.gov, where an agenda and any 

additional information for the meeting will 

be posted when available. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.14, Intramural Research 

Training Award; 93.22, Clinical Research 

Loan Repayment Program for Individuals 

from Disadvantaged Backgrounds; 93.232, 

Loan Repayment Program for Research 

Generally; 93.39, Academic Research 

Enhancement Award; 93.936, NIH Acquired 

Immunodeficiency Syndrome Research Loan 

Repayment Program; 93.187, Undergraduate 

Scholarship Program for Individuals from 

Disadvantaged Backgrounds, National 

Institutes of Health, HHS) 

Dated: January 25, 2010. 

Jennifer Spaeth, 

Director, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2010–1897 Filed 1–29–10; 8:45 am] 

BILLING CODE 4140–01–M 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Agency for Healthcare Research and 

Quality 

Notice of Meeting 

In accordance with section 10(d) of 

the Federal Advisory Committee Act (5 

U.S.C., Appendix 2), announcement is 

made of a Health Care Policy and 

Research Special Emphasis Panel (SEP) 

meeting. 

A Special Emphasis Panel is a group 

of experts in fields related to health care 

research who are invited by the Agency 

for Healthcare Research and Quality 

(AHRQ), and agree to be available, to 

conduct on an as needed basis, 

scientific reviews of applications for 

AHRQ support. Individual members of 

the Panel do not attend regularlyscheduled meetings and do not serve for 

fixed terms or a long period of time. 

Rather, they are asked to participate in 

particular review meetings which 

require their type of expertise. 

Substantial segments of the upcoming 

SEP meeting listed below will be closed 

to the public in accordance with the 

Federal Advisory Committee Act, 

section 10 (d) of 5 U.S.C., Appendix 2 

and 5 U.S.C. 552b(c)(6). Grant 

applications for the ARRA: Limited 

Competition ‘‘NRSA CE Development 

Award’’ (T32) applications are to be 

reviewed and discussed at this meeting. 

These discussions are likely to reveal 

personal information concerning 

individuals associated with the 

applications. This information is 

exempt from mandatory disclosure 

under the above-cited statutes. 

SEP Meeting on: ARRA: Limited 

Competition ‘‘NRSA CE Development Award’’ 

(T32) 

Date: March 3, 2010 (Open on March 3 

from 1 p.m. to 1:15 p.m. and closed for the 

remainder of the meeting). 

Place: Hilton Rockville Executive Meeting 

Center, 1750 Rockville Pike, Madison 

Conference Room, Rockville, Maryland 

20850. 

Contact Person: Anyone wishing to obtain 

a roster of members, agenda or minutes of the 

nonconfidential portions of this meeting 

should contact Mrs. Bonnie Campbell, 

Committee Management Officer, Office of 

Extramural Research, Education and Priority 

Populations, AHRQ, 540 Gaither Road, Room 

2038, Rockville, Maryland 20850, Telephone 

(301) 427–1554. 

Agenda items for this meeting are subject 

to change as priorities dictate. 

Dated: January 25, 2010. 

Carolyn M. Clancy, 

Director. 

[FR Doc. 2010–1896 Filed 1–29–10; 8:45 am] 

BILLING CODE 4160–90–M 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Agency for Healthcare Research and 

Quality 

Notice of Meetings 

In accordance with section 10(d) of 

the Federal Advisory Committee Act as 

amended (5 U.S.C., Appendix 2), the 

Agency for Healthcare Research and 

Quality (AHRQ) announces meetings of 

scientific peer review groups. The 

subcommittees listed below are part of 

the Agency’s Health Services Research 

Initial Review Group Committee. 

The subcommittee meetings will be 

closed to the public in accordance with 

the Federal Advisory Committee Act, 

section 10(d) of 5 U.S.C., Appendix 2 

and 5 U.S.C. 552b(c)(6). Grant 

applications are to be reviewed and 

discussed at these meetings. These 

discussions are likely to involve 

information concerning individuals 

associated with the applications, 

including assessments of their personal 

qualifications to conduct their proposed 

projects. This information is exempt 

from mandatory disclosure under the 

above-cited statutes. 

1. Name of Subcommittee: Health Care 

Technology and Decision Sciences. 

Date: February 23–25, 2010 (Open from 8 

a.m. to 8:15 a.m. on February 23 and closed 

for remainder of the meeting). 

Place: Marriott Bethesda North Hotel & 

Conference Center, 5701 Marinelli Road, 

Forest Glen Conference Room, Bethesda, MD 

20852. 

2. Name of Subcommittee: Health Systems 

Research. 

Date: February 24–25, 2010 (Open from 8 

a.m. to 8:15 a.m. on February 24 and closed 

for remainder of the meeting). 

Place: Marriott Bethesda North & 

Conference Center, 5701 Marinelli Road, 

Linden Oak Conference Room, Bethesda, MD 

20852. 

3. Name of Subcommittee: Health Care 

Quality and Effectiveness Research. 

Date: March 3–4, 2010 (Open from 8:30 

a.m. to 8:45 a.m. on March 3 and closed for 

remainder of the meeting). 


jlentini on DSKJ8SOYB1PROD with NOTICES